- Home
- » Tags
- » Dyslipidemia
Top View
- D25V Apolipoprotein C-III Variant Causes Dominant Hereditary Systemic Amyloidosis and Confers Cardiovascular Protective Lipoprotein Profile
- Dyslipidemia and Its Associated Factors in Southern Iranian Women
- Efficacy of Polyphenols in the Management of Dyslipidemia
- Management of Severe Hypertriglyceridemia Due to Lipoprotein Lipase Deficiency in Children
- Dyslipidemia
- Abstract Familial Combined Hyperlipidemia the Most Common
- VA/Dod CLINICAL PRACTICE GUIDELINE for the MANAGEMENT of DYSLIPIDEMIA
- Tuberous Xanthomas in the Setting of Mild Dyslipidemia
- Current Diagnosis and Management of Abetalipoproteinemia
- DENND5B Regulates Intestinal Triglyceride Absorption and Body Mass Received: 11 June 2018 Scott M
- Rare Dyslipidaemias, from Phenotype to Genotype to Management: a European Atherosclerosis Society Task Force Consensus Statement
- The Work-Up for Mixed Hyperlipidemia: a Case Study
- Treatment for Dyslipidemia in Older Age: Who Should Be Treated?
- Dyslipidemia Prevention and Management
- Uncommon Dyslipidemias with Common Presentations James A
- Supplementary Materials Table S1. List of 63 Evaluated Genes Related to Dyslipidemia and Premature Atherosclerosis with Associated Phenotypes
- Screening and Treatment for Hypercholesterolemia in Children And
- Eruptive Xanthoma
- The Diagnosis and Management of Lipodystrophy Syndromes: a Multi-Society Practice Guideline
- Hypertriglyceridemia: Its Etiology, Effects and Treatment
- Diagnosis and Treatment of High Density Lipoprotein Deficiency
- Management of Hypertriglyceridemia: Common Questions and Answers
- Evidence from Lipoprotein Lipase Gene
- Abetalipoproteinemia Induced by Overexpression of ORP150 in Mice
- Dyslipidemia, Cholesterol, Arterial Hypertension, Monitoring
- High-Density Lipoproteins and the Kidney
- Management of Hypertriglyceridemia BMJ: First Published As 10.1136/Bmj.M3109 on 12 October 2020
- Management of Hypertriglyceridemia BMJ: First Published As 10.1136/Bmj.M3109 on 12 October 2020
- Phenotypes of Dyslipidemia Disclosures
- The Mechanism of Protease Inhibitor Induced Dyslipidemia and Lipodystrophy
- Table 1. Genetic Classification of Dyslipidemia
- 2008 Guideline for the Diagnosis and Management of Dyslipidemia for Adults > 18 Years of Age
- Dyslipidemia
- 2018 Guideline on the Management of Blood Cholesterol
- Persistent Dyslipidemia in Treatment of Lysosomal Acid Lipase Deficiency Amanda Barone Pritchard2†, Alanna Strong1† and Can Ficicioglu1*
- Establishment of Reference Values of Α-Tocopherol in Plasma, Red Blood
- Tuberous Xanthomatosis As a Presentation of Familial Hypercholester- Olemia
- Familial Hypercholesterolemia: Screening, Diagnosis
- Hypertriglyceridemia: Why, When, and How to Treat
- CCS Dyslipidemia Guidelines (2006, 2009, 2012 and 2016)
- Diagnosis and Clinical Appraisal